Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP1 Study in Hypopituitarism
NCT04897802Phase 4Completed
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Sep 2021
- Primary completion
- Apr 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in hypopituitarism, Oxytocin deficiency, sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Started Sep 2021; status: completed.
02
Drugs
exenatide
03
Conditions
hypopituitarismOxytocin deficiency
Beyond the preview
Go deeper on NCT04897802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04897802.